K. Song, A. M. Fendric and U. Ladabaum,” Fecal DNA Testing Compared with Conventional Colorectal Cancer Screening Methods: A Decision Analysis,” Journal of Gastroenterology, Vol. 126, No. 5, 2004, pp. 1270-1279. doi:10.1053/j.gastro.2004.02.016

has been cited by the following article:

• TITLE: Pseudobezoars: Technology Progress and New Prospects as a Medical Platform

  AUTHORS: Orly Yadid-Pecht, Martin P. Mintchev

  KEYWORDS: Pseudobezoars; Obesity; Colon Cancer Screening; Diagnostic Device; Therapeutic Device

  JOURNAL NAME: Engineering, Vol.5 No.5B, July 26, 2013

  ABSTRACT: In recent years, pseudobezoars have been a subject of research, mainly serving as a basis for a new non-invasive alternative to obesity treatment. A pill incorporating the technology has been proven to be successful as a weight loss therapy. It enables patients to sustain a diet longer, due to an increase in the level of satiety, resulting in a smaller amount of food intake. Utilization of the technology has recently found new prospects in another organ of the GI tract, the colon. Pseudobezoar technology can be utilized as an enhanced method for colon cancer screening and also as an alternative carrier for bacterial therapy.